Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.
Author
Summary, in English
The DIRECT (Diabetes Research on Patient Stratification) Study is part of a European Union Framework 7 Innovative Medicines Initiative project, a joint undertaking between four industry and 21 academic partners throughout Europe. The Consortium aims to discover and validate biomarkers that: (1) predict the rate of glycaemic deterioration before and after type 2 diabetes onset; (2) predict the response to diabetes therapies; and (3) help stratify type 2 diabetes into clearly definable disease subclasses that can be treated more effectively than without stratification. This paper describes two new prospective cohort studies conducted as part of DIRECT.
Department/s
Publishing year
2014
Language
English
Pages
1132-1142
Publication/Series
Diabetologia
Volume
57
Issue
6
Full text
- Available as PDF - 300 kB
- Download statistics
Links
Document type
Journal article
Publisher
Springer
Topic
- Endocrinology and Diabetes
Status
Published
Research group
- Genetic and Molecular Epidemiology
- Diabetes - Clinical Obesity
ISBN/ISSN/Other
- ISSN: 1432-0428